HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: AJPH.2007.129528v1 99/2/340    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Andia, I. Articles by Hogg, R. S. Search for Related Content PubMed PubMed Citation Articles by Andia, I. Articles by Hogg, R. S. Related Collections Contraception Global Health Other Health Financing Access to Care HIV/AIDS Prevention Sexual Health Women's Health

Irene Andia, MB, ChB, MMed, Angela Kaida, MSc, Marissa Maier, MD, David Guzman, MSPH, Nneka Emenyonu, MPH, Larry Pepper, DO, MSPM, David R. Bangsberg, MD, MPH and Robert S. Hogg, PhD

Irene Andia is with the Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. Angela Kaida is with the Department of Health Care and Epidemiology, Faculty of Medicine, University of British Columbia, Vancouver. Marissa Maier is with the Department of Internal Medicine, Oregon Health & Science University, Portland. David Guzman and Nneka Emenyonu are with the Department of Internal Medicine, University of California, San Francisco. Larry Pepper is with the Mbarara University of Science and Technology, Mbarara. David R. Bangsberg is with Harvard Medical School/Massachusetts General Hospital, Boston. Robert S. Hogg is with the BC Centre for Excellence in HIV/AIDS, Vancouver.

Correspondence: Requests for reprints should be sent to Irene Andia, MB, ChB, MMed, Mbarara University of Science and Technology, PO Box 1410, Mbarara, Uganda (e-mail: andiaodanga{at}yahoo.com).

Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda.

Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18–50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006.

Results. Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR] = 2.64; 95% confidence interval [CI] = 1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR = 3.62; 95% CI = 1.54, 8.55) than were women not receiving HAART.

Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.